Literature DB >> 14671668

Topical administration of a novel nitric oxide donor, linear polyethylenimine-nitric oxide/nucleophile adduct (DS1), selectively increases vaginal blood flow in anesthetized rats.

P Pacher1, J G Mabley, L Liaudet, O V Evgenov, G J Southan, G E Abdelkarim, C Szabó, A L Salzman.   

Abstract

The aim of the present study was to test the effects of a topical administration of a novel nitric oxide donor, linear polyethylenimine-nitric oxide/nucleophile adduct (DS1), on vaginal blood flow and hemodynamics in rats. Laser Doppler flowmetry was used to measure blood flow changes following topical application of DS1 (0.3 or 1.5 mg in 0.15 ml saline) into the vagina of anesthetized Wistar rats. In vivo hemodynamic parameters were measured with Millar-tip-catheter placed in the left ventricle. DS1 (1.5 mg) increased vaginal blood flow by 191+/-24, 226+/-22 and 166+/-23% of the baseline value (at 5, 15 and 30 min, respectively, after application) without affecting systemic blood pressure, heart rate and cardiac function. The increased vaginal blood flow following DS1 application returned to baseline between 45 and 60 min. Thus, topical application of nitric oxide donors such as DS1 may be useful for the treatment of female sexual dysfunction that develops due to an impairment of local blood flow supply to the vaginal tissue.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14671668     DOI: 10.1038/sj.ijir.3901045

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  4 in total

1.  Treatment of blood flow abnormality using mucosal delivery of nitric oxide.

Authors:  Chi H Lee
Journal:  Drug Deliv Transl Res       Date:  2011-06       Impact factor: 4.617

Review 2.  Female sexual dysfunction: therapeutic options and experimental challenges.

Authors:  Kyan J Allahdadi; Rita C A Tostes; R Clinton Webb
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2009-10

Review 3.  Endothelial nitric oxide synthase regulation in female genital tract structures.

Authors:  Biljana Musicki; Tongyun Liu; Gwen A Lagoda; Trinity J Bivalacqua; Travis D Strong; Arthur L Burnett
Journal:  J Sex Med       Date:  2008-12-05       Impact factor: 3.802

Review 4.  Potential future options in the pharmacotherapy of female sexual dysfunction.

Authors:  Stefan Uckert; Margit E Mayer; Udo Jonas; Christian G Stief
Journal:  World J Urol       Date:  2006-12       Impact factor: 3.661

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.